BLSR.TA
Blue Square Real Estate Ltd [BLSR.TA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BLSR.TA Stock Summary
Top 10 Correlated ETFs
BLSR.TA
Top 10 Correlated Stocks
BLSR.TA
In the News
BLSR.TA Financial details
Company Rating
Buy
Market Cap
3.2B
Income
633.7M
Revenue
543.43M
Book val./share
-
Cash/share
-
Dividend
16.39
Dividend %
0.07%
Employees
53
Optionable
No
Shortable
Yes
Earnings
31 Mar 2024
P/E
8.59
Forward P/E
-
PEG
-5.24
P/S
5.54
P/B
0.92
P/C
-
P/FCF
8.59
Quick Ratio
2.82
Current Ratio
4.46
Debt / Equity
1.52
LT Debt / Equity
1.15
-
-
EPS (TTM)
20.27
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
19.48%
Revenue Q/Q
-18.6%
EPS Q/Q
-
-
-
-
-
SMA20
7.67%
SMA50
12.56%
SMA100
19.78%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
11%
ROC
0.07%
Gross Margin
70%
Oper. Margin
114%
Profit Margin
64%
Payout
29%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
16900.0-28700.0
52W High
-5.99%
52W Low
+59.64%
RSI
53
Rel Volume
1.72
Avg Volume
7.97K
Volume
13.72K
Perf Week
-4.9%
Perf Month
4.86%
Perf Quarter
36.26%
Perf Half Y
31.93%
-
-
-
-
Beta
1.04
-
-
Volatility
908.75%, 1188.25%
Prev Close
3.17%
Price
26980
Change
5.8%
BLSR.TA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 19.27 | 26.87 | 32.72 | 34.89 | 0 | |
| Net income per share | 29.65 | 16.21 | 47.51 | 24.24 | 0 | |
| Operating cash flow per share | 11.77 | 10.76 | 27 | 25.01 | 0 | |
| Free cash flow per share | 7.81 | 5.54 | 27 | 25.01 | 0 | |
| Cash per share | 22.96 | 98.15 | 92.91 | 113.58 | 0 | |
| Book value per share | 185.18 | 192.81 | 229.03 | 248.38 | 0 | |
| Tangible book value per share | 185.18 | 192.6 | 228.9 | 248.35 | 0 | |
| Share holders equity per share | 185.18 | 192.81 | 229.03 | 248.38 | 0 | |
| Interest debt per share | 303.11 | 390.09 | 398.06 | 437.49 | 0 | |
| Market cap | 2.83B | 2.4B | 3.29B | 2.54B | 0 | |
| Enterprise value | 6.2B | 6.17B | 7.53B | 6.74B | 4.46B | |
| P/E ratio | 8.24 | 12.77 | 5.91 | 8.6 | 0 | |
| Price to sales ratio | 12.67 | 7.7 | 8.59 | 5.98 | 0 | |
| POCF ratio | 20.74 | 19.23 | 10.41 | 8.34 | 0 | |
| PFCF ratio | 31.25 | 37.33 | 10.41 | 8.34 | 0 | |
| P/B Ratio | 1.32 | 1.07 | 1.23 | 0.84 | 0 | |
| PTB ratio | 1.32 | 1.07 | 1.23 | 0.84 | 0 | |
| EV to sales | 27.78 | 19.83 | 19.69 | 15.83 | 8.2 | |
| Enterprise value over EBITDA | 12.6 | 21.51 | 9.86 | 10.55 | 4.53 | |
| EV to operating cash flow | 45.46 | 49.52 | 23.86 | 22.1 | 13.62 | |
| EV to free cash flow | 68.49 | 96.12 | 23.86 | 22.1 | 13.62 | |
| Earnings yield | 0.12 | 0.08 | 0.17 | 0.12 | 0 | |
| Free cash flow yield | 0.03 | 0.03 | 0.1 | 0.12 | 0 | |
| Debt to equity | 1.61 | 1.99 | 1.68 | 1.66 | 1.52 | |
| Debt to assets | 0.55 | 0.6 | 0.56 | 0.57 | 0.54 | |
| Net debt to EBITDA | 6.85 | 13.16 | 5.56 | 6.57 | 4.53 | |
| Current ratio | 0.78 | 0.75 | 2.32 | 3.28 | 1.47 | |
| Interest coverage | 7.46 | 4.12 | 4.71 | 2.28 | 4.31 | |
| Income quality | 0.3 | 0.54 | 0.45 | 0.92 | 0.41 | |
| Dividend Yield | 0.03 | 0.03 | 0.06 | 0.03 | 0 | |
| Payout ratio | 0.27 | 0.32 | 0.36 | 0.27 | 0.16 | |
| Sales general and administrative to revenue | 0.04 | 0.05 | 0.03 | 0.04 | 0.04 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.81 | 0.83 | 0.78 | 0 | |
| Capex to operating cash flow | -0.34 | -0.48 | 0 | 0 | 0 | |
| Capex to revenue | -0.21 | -0.19 | 0 | 0 | 0 | |
| Capex to depreciation | -34.72 | -16.07 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 351.46 | 265.16 | 494.82 | 368.03 | 0 | |
| ROIC | 0.07 | 0.03 | 0.08 | 0.07 | 0.09 | |
| Return on tangible assets | 0.05 | 0.13 | 0.42 | 0.15 | 0.06 | |
| Graham Net | -324.35 | -333.94 | -347.91 | -352.51 | 0 | |
| Working capital | -169.47M | -500.01M | 1B | 1.44B | 714.38M | |
| Tangible asset value | 2.15B | -3.71B | -3.97B | -3.92B | 3.47B | |
| Net current asset value | -3.57B | -3.66B | -3.54B | -3.8B | -4.08B | |
| Invested capital | 1.61 | 1.99 | 1.68 | 1.66 | 1.52 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 22.06M | 27.43M | 28.45M | 34.98M | 37.02M | |
| Average inventory | 129.53M | 268.14M | 282.99M | 331.09M | 366.26M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 1.19K | 326.16 | 140.45 | 146.95 | 75.55 | |
| Days of inventory on hand | 10.88K | 3.42K | 1.33K | 1.39K | 786.18 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0.31 | 1.12 | 2.6 | 2.48 | 4.83 | |
| Inventory turnover | 0.03 | 0.11 | 0.27 | 0.26 | 0.46 | |
| ROE | 0.16 | 0.08 | 0.21 | 0.1 | 0.18 | |
| Capex per share | -3.96 | -5.22 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 9.44 | 9.98 | 11.32 | 12.82 | 0 | |
| Net income per share | 7.79 | 3.85 | 11.05 | 5.37 | 0 | |
| Operating cash flow per share | 7.07 | 8.12 | 7.61 | 5.28 | 0 | |
| Free cash flow per share | 7.07 | 8.12 | 7.61 | 5.28 | 0 | |
| Cash per share | 113.57 | 120.04 | 91.84 | 100.45 | 0 | |
| Book value per share | 248.38 | 244.41 | 255.47 | 261.11 | 0 | |
| Tangible book value per share | 248.34 | 244.4 | 255.48 | 261.13 | 0 | |
| Share holders equity per share | 248.38 | 244.41 | 255.47 | 261.11 | 0 | |
| Interest debt per share | 412.97 | 423.03 | 407.94 | 413.09 | 0 | |
| Market cap | 2.54B | 2.38B | 2.62B | 2.68B | 0 | |
| Enterprise value | 6.74B | 6.53B | 6.91B | 7.01B | 4.46B | |
| P/E ratio | 6.69 | 12.66 | 4.86 | 10.23 | 0 | |
| Price to sales ratio | 22.09 | 19.54 | 18.96 | 17.16 | 0 | |
| POCF ratio | 29.51 | 24.01 | 28.21 | 41.64 | 0 | |
| PFCF ratio | 29.51 | 24.01 | 28.21 | 41.64 | 0 | |
| P/B Ratio | 0.84 | 0.8 | 0.84 | 0.84 | 0 | |
| PTB ratio | 0.84 | 0.8 | 0.84 | 0.84 | 0 | |
| EV to sales | 58.54 | 53.66 | 50.03 | 44.85 | 35.01 | |
| Enterprise value over EBITDA | 55.71 | 53.65 | 28.47 | 54.21 | 8.51 | |
| EV to operating cash flow | 78.2 | 65.93 | 74.43 | 108.87 | 62.85 | |
| EV to free cash flow | 78.2 | 65.93 | 74.43 | 108.87 | 62.85 | |
| Earnings yield | 0.04 | 0.02 | 0.05 | 0.02 | 0 | |
| Free cash flow yield | 0.03 | 0.04 | 0.04 | 0.02 | 0 | |
| Debt to equity | 1.66 | 1.71 | 1.57 | 1.57 | 1.52 | |
| Debt to assets | 0.57 | 0.56 | 0.55 | 0.55 | 0.54 | |
| Net debt to EBITDA | 34.68 | 34.11 | 17.68 | 33.48 | 8.51 | |
| Current ratio | 3.28 | 2.81 | 4.69 | 4.46 | 1.47 | |
| Interest coverage | -73.03 | 1.59 | 2.85 | 1.9 | 24.71 | |
| Income quality | 0.71 | 1.95 | 0.57 | 0.86 | 0.14 | |
| Dividend Yield | 0 | 0 | 0.04 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0.74 | 0 | 0 | |
| Sales general and administrative to revenue | -0.13 | 0.1 | 0.08 | 0.1 | -0.15 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.78 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 208.63 | 145.51 | 252.04 | 177.64 | 0 | |
| ROIC | 0.02 | 0.01 | 0.02 | 0.01 | 0.05 | |
| Return on tangible assets | 0.05 | 0.01 | 0.02 | 0.01 | 0.04 | |
| Graham Net | -352.5 | -360.23 | -364.22 | -364.03 | 0 | |
| Working capital | 1.44B | 1.38B | 1.43B | 1.51B | 714.38M | |
| Tangible asset value | -3.92B | 2.98B | 3.12B | 3.19B | 3.47B | |
| Net current asset value | -3.8B | -3.9B | -3.92B | -3.9B | -4.08B | |
| Invested capital | 1.66 | 1.71 | 1.57 | 1.57 | 1.52 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 36.35M | 41.19M | 48.14M | 47.2M | 37.75M | |
| Average inventory | 376.46M | 372.5M | 367.91M | 356.91M | 354.33M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 117.23 | 133.88 | 114.37 | 65.71 | 78.18 | |
| Days of inventory on hand | 1.11K | 1.16K | 779.9 | 560.36 | 813.53 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0.77 | 0.67 | 0.79 | 1.37 | 1.15 | |
| Inventory turnover | 0.08 | 0.08 | 0.12 | 0.16 | 0.11 | |
| ROE | 0.03 | 0.02 | 0.04 | 0.02 | 0.11 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
BLSR.TA Frequently Asked Questions
What is Blue Square Real Estate Ltd stock symbol ?
Blue Square Real Estate Ltd is a IL stock and trading under the symbol BLSR.TA
What is Blue Square Real Estate Ltd stock quote today ?
Blue Square Real Estate Ltd stock price is $26980 today.
Is Blue Square Real Estate Ltd stock public?
Yes, Blue Square Real Estate Ltd is a publicly traded company.
Company Profile
- Volume Average 7.97K
- Market Capitalization 3.2B
- Employee 53
- CEO Mr. Arthur Lashinski
- Headquarters Tel Aviv,IL
- IPO Date 2006-08-29
-
Website
https://www.bsi.co.il 
Blue Square Real Estate Ltd develops, owns, leases, manages, and sells real estate properties in Israel. It offers retail, commercial, office, and logistic, as well as residential properties. The company was incorporated in 2005 and is based in Tel Aviv-Yafo, Israel. Blue Square Real Estate Ltd is a subsidiary of Alon Blue Square Israel Ltd.
